Advertisement

Topics

Eisai Inc. Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study Will Continue As Planned Based On Interim Safety Analysis By Independent Data Monitoring Committee (DMC)

20:00 EDT 20 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Eisai Inc. Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study Will Continue As Planned Based On Interim Safety Analysis By Independent Data Monitoring Committee (DMC)

NEXT ARTICLE

More From BioPortfolio on "Eisai Inc. Announces Lorcaserin HCl CAMELLIA-TIMI 61 Study Will Continue As Planned Based On Interim Safety Analysis By Independent Data Monitoring Committee (DMC)"

Advertisement
Quick Search
Advertisement
Advertisement